. Ingestion ofllmnioticfluid enhances opiate analgesia in rats. PHYSIOL BEHAV 38(6) [809][810][811][812][813][814][815] 1986.-Placenta ingestion has recently been shown to enhance opiate-mediated analgesia produced by morphine injection, footshock, or vaginal/cervical stimulation. The enhancement of the effect of endogenous opiates (especially analgesia) may be one of the principal benefits to mammalian mothers of placentophagia at delivery. During labor and delivery, however, mothers also ingest amniotic fluid (AF) which, unlike placenta, becomes available during, or even before expulsion of the infant. The present experiments were undertaken to determine (a) whether AF ingestion, too, enhances analgesia; if so, (b) whether the effect requires ingestion of, or merely exposure to, AF; (c) whether the effect can be produced by AF delivered directly to the stomach by tube; and (d) whether the enhancement, if it exists, can be blocked by administering an opiate antagonist. Nulliparous Long-Evans rats were tested for analgesia using tail-flick latency. We found that (a) rats that ingested AF after receiving a morphine injection showed significantly more analgesia than did rats that ingested a control substance;' (b) AF ingestion, alone, did not produce analgesia; (c) ingestion of AF, rather than just smelling and seeing it, was necessary to produce analgesia enhancement; (d) AF produced enhance ment when oropharyngeal factors were eliminated by delivering it through an orogastric tube; and (e) treatment of the rats with naltrexone blocked the enhancement of morphine-induced analgesia that results from AF ingestion. . Furthermore, placenta does not seem to contain a substance that, by itself, is analgesic, since in gestion of placenta in the absence of an analgesia-producing treatment does not elevate pain threshold [15, 16] . We have also demonstrated that the analgesia-enhancing effect of placenta ingestion seems to be specific to opiate-mediated analgesia, since treatment with naltrexone, an opiate antagonist, not only attenuates the analgesia produced by footshock, as expected, but also blocks the enhancing effect of placenta ingestion [15] . Endogenous opiate levels rise during pregnancy and de livery in both humans and rats [4, 6, 9, 12, 13, [19] [20] [21] [22] [23]. Pain threshold has been observed to rise over the course of preg nancy in rats, and this "analgesia of pregnancy" has been demonstrated to be opiate mediated [1, 7, 8] . Enhancement of such analgesia, therefore, may be one of the principal benefits of parturitional placentophagia, and, in contrast to other hypotheses about advantages (e.g., nest hygiene, mother-infant attachment, reduction of predator-attracting stimuli [14, 17] ), this hypothesis suggests a benefit that would apply to virtually all species of mammals.
WE have recently demonstrated that the effect of opiate mediated analgesia in rats (as measured by tail-flick latency) is enhanced if the rats ingest placenta, but not if they ingest ground beef or cookie mash. We have found this enhance ment with morphine-induced analgesia [15] , footshock induced analgesia [15] , and vaginallcervical-stimulation induced analgesia [16] . Furthermore, placenta does not seem to contain a substance that, by itself, is analgesic, since in gestion of placenta in the absence of an analgesia-producing treatment does not elevate pain threshold [15, 16] . We have also demonstrated that the analgesia-enhancing effect of placenta ingestion seems to be specific to opiate-mediated analgesia, since treatment with naltrexone, an opiate antagonist, not only attenuates the analgesia produced by footshock, as expected, but also blocks the enhancing effect of placenta ingestion [15] .
Endogenous opiate levels rise during pregnancy and de livery in both humans and rats [4, 6, 9, 12, 13, [19] [20] [21] [22] [23] . Pain threshold has been observed to rise over the course of preg nancy in rats, and this "analgesia of pregnancy" has been demonstrated to be opiate mediated [1, 7, 8] . Enhancement of such analgesia, therefore, may be one of the principal benefits of parturitional placentophagia, and, in contrast to other hypotheses about advantages (e.g., nest hygiene, mother-infant attachment, reduction of predator-attracting stimuli [14, 17] ), this hypothesis suggests a benefit that would apply to virtually all species of mammals.
However, if placenta, alone, contains the substance that enhances opiate-mediated analgesia during the perinatal period, the fact that placenta is delivered after the neonate (anywhere from 5 to 75 min after) would render it effective only during the delivery of later infants in litters of mothers of polytocous species, or only in the postpartum period in mothers of monotocous species. On the other hand, if the opiate-enhancing substance is also pr~sent in amniotic fluid, then the effect on pain threshold would be realized during, if not before, delivery of the first infant, since amniotic fluid is available to the mother during and often before the emergence of the first infant.
The present series of experiments was designed to de termine whether ingestion of amniotic fluid enhances opiate-mediated analgesia in rats. When we determined that it does, we then sought to determine whether the sight and smell of amniotic fluid could enhance analgesia, perhaps by producing an endorphin release in the same way that the sight of a cat produces an endorphin release in rats [5] , whether oral sensory cues (e.g., taste) were involved in the response of the eater, and whether analgesia enhancement is specific to the opiate effects of morphine.
EXPERIMENT 1
In the first experiment we tested whether ingestion of amniotic fluid would elevate the tail-flick latencies of rats lRequests for reprints should be addressed to Dr. Mark B. Kristal, Department of Psychology, Park Hall, State University of New York at Buffalo, Buffalo, NY 14260. 810 that had received a threshold dose of morphine. The details of this experiment are almost identical to one reported previ ously [15] .
METHOD

Subjects
Thirty-two vIrgm female Long-Evans rats, at least 90 days of age, and having normal estrous cycles, were used in this experiment. All rats were subjected to a 14 hr onllO hr off light/dark cycle, with the light phase beginning at 0600 (EST). Tests were conducted between 0800 and 1030. Upon entry into the experiment, each rat was housed individually in a 24.5 x 18 x 18-cm hanging, wire-mesh cage. Food (Ag way Rat/Mouse/Hamster Formula 3000) and water were available ad lib, except for the 2-hr period before testing, and during the actual tests. Pre-exposing the rats to the test material several times ensured that each future subject was willing to eat all the material presented, within a 15-min period. All the rats in Experiment 1 had previously partici pated in another study in which they had been exposed to the intubation procedure described in Experiment 3, and had received one 3 mg/kg injection of morphine sulfate.
Apparatus
Pain thresholds were measured with the same "tail-flick" algesiometer described previously [15] , which is similar to the standard apparatus used in many laboratories [2, 3] . Heat produced by a 500-W projecter lamp was beamed through a 1.8-cm aperture at a rat's tail 2 cm away. When the heat became uncomfortable, the rat's tail moved and the stimulus was immediately terminated. The bulb output was moni tored, and input was increased by means of a potentiometer, as the bulb aged. Initially, the bulb was set below maximum output, and was calibrated to produce a tail flick in 3-4 sec in a normal rat. If no response occurred, the trial was termi nated at 8 sec to prevent tissue damage in subjects experienc ing analgesia. The number of seconds that elapsed before the rat moved its tail from the stimulus field after the onset of the heat (tail-flick latency, or TFL) was the dependent variable. Each TFL was the mean of the last 3 of 4 consecutive trials, which were separated by 30-sec intervals. Rats were re strained in an opaque polyvinyl tube (5 x 21 cm) to which they had been habituated previously.
Procedure
The 32 rats were evenly divided among four groups. The first and second groups received a threshold dose of mor phine (3 mg/kg morphine sulfate, IP) followed by exposure to a mixture of either 1 ml amniotic fluid in 1 g ground beef (Group M/AF) or 1 ml beef bouillon in 1 g ground beef (Group M/BB). The third and fourth groups received saline rather than morphine (1 ml/kg, IP) and were then presented with either the amniotic fluid + beef mixture (Group S/AF) or bouillon + beef mixture (Group S/BB).
Amniotic fluid was obtained surgically from Day 21 preg nant donors killed with CO 2 , The uterus was opened from the ends and the feto-placental units, each in its own sac, were extruded. A small puncture was made in the amniotic mem brane and the amniotic fluid was drained into a glass dish. All the amniotic fluid collected from the fetuses of one adult was stored in one vial. The vials of amniotic fluid were quickly KRISTAL, THOMPSON AND ABBOTT frozen at -20°C and stored until needed. For presentation, each vial was warmed to 37°C.
Beef bouillon (Wylers instant) was prepared in half the concentration specified in the directions, then frozen, stored and subsequently handled just as amniotic fluid.
For presentation, the amniotic fluid and beef bouillon (1 ml) were mixed with 1 g fresh ground beef (sirloin). We felt that this would provide the rat with a substance that, in texture and composition, more closely approximated after birth material than did straight amniotic fluid. In addition, the beef mixture was easier to handle and present than a relatively thin liquid. and it was less likely to be refused by those nulliparous rats that apparently regard afterbirth material as aversive [14] .
Each rat was food deprived for the 2-hr period preceding the test, and food and water deprived during the test.
During the test, each subject first underwent a baseline TFL determination (Til)' followed immediately by the mor phine or saline injection. Fifteen minutes after injection, each rat was presented with the beef mixture in an untippa ble glass dish. After 20 min, the rat was again tested for TFL (To), then three more times at 30-min intervals (Tao, T6lh T90)' This resulted in a 2x2x5 design: Drug (morphine,saline) x "Food" (amniotic fluid + beef, bouillon + beet) x Time, with repeated measures on the Time variable.
The rat was housed in a holding cage during the intervals between TFL tests. For all the experiments reported here, the experimenter conducting the TFL tests was blind to the condition of the rats.
RESULTS AND DISCUSSION
The results of the first experiment are presented in Fig. 1 . There were no significant differences between the mean baseline TFLs of the four groups: Group M/AF, 3.56±0.11 sec; Group M/BB, 3.52±0.04 sec; Group S/AF, 3.46±0.11 sec; Group S/BB, 3.46±0.11 sec.
A 3-way ANOYA revealed a significant Food x Drug interaction, F(l ,28)=6.39, p<O.OI, a significant main effect of Time, F(l,129)=7.84, p<O.OOI (with a Greenhouse Geisser probability correction), and a significant Time x Drug interaction, F(4,129)=3.08, p<0.05 (with a Greenhouse Geisser correction).
Probes of the Food x Drug interaction on the different tests revealed that at To, Group M/AF (mean=5.02±0.31 sec) showed significantly longer TFLs than Group M/BB (3.80±0.16 sec), F(l, 129)=20.59, p<O.OI, and than Group S/AF (3.86±0.14), F(l, 129)= 18.79, p<O.Ol. There were no significant differences between Group S/AF and Group S/BB, or between Group M/BB and Group S/BB. At T:w, the differences seen at To were sustained: Group M/AF (4.51 ±0.47 sec) showed significantly longer TFLs than either Group M/BB (3.87±0.33 sec), F(l, 129)=5.55, p<0.05, or Group S/AF (3.39±0.07 sec), F(l, 129)= 17.41, p<O.Ol. There were no significant differences between Group S/AF (3.39±0.07 sec) and Group S/BB (3.57±0.12 sec), or between Group M/BB (3.87±0.33 sec) and Group S/BB.
There were no significant differences between groups at either T60 or T90' There were no significant correlations be tween stage of the estrous cycle on the day of testing and the magnitude of the TFL.
The results of Experiment 1, that amniotic-fluid ingestion enhances analgesia produced by morphine injection, but +-60 does not, by itself, produce analgesia, are consistent with our previous report on the effects of placenta ingestion on morphine-induced analgesia [15] . The effect of amniotic-fluid ingestion is more modest than the effect of placenta inges tion: ingestion of 4 g placenta produced an increase in TFL of nearly 71% (over morphine controls) in 20 min, whereas ingestion of 1 ml amniotic fluid elevated TFL by about 30-35% in the same amount of time. There is no reason to assume, of course, that 4 g placenta and 1 ml amniotic fluid are equivalent doses, but some pilot work we have con ducted on different doses of amniotic fluid indicates that a 45-50% increase in TFL, over that produced by morphine alone, may be the maximum change.
EXPERIMENT 2
Apparently, rats show an endorphin release when con fronted with certain "naturalistic activating" stimuli, such as the odors released from stressed rats [5] , or the sight of a live cat [18] . Afterbirth material may be in the same category of stimuli for virgin rats; their response to it is intense but dichotomous. Some virgin rats (and mice) approach it and consume it immediately, completely, and avidly. The rest behave as if they are afraid of it, backing into a corner, attempting to leap out of the cage, or in the case of mice, rattling their tails [14] .
It is possible then, that the opiate-enhancement effect we observed was due to the initial response the rats have to the smell and perhaps sight of the afterbirth material, rather than one specifically resulting from ingesting the material. In Ex periment 1 and in our previous papers [15, 16] , the rats that ate the material were the only ones that saw and smelled it. Therefore, the present experiment was designed to deter mine whether seeing and smelling amniotic fluid (and beef), but not ingesting it, is sufficient to produce enhancement of opiate-mediated analgesia.
METHOD
Subjects
Sixteen Long-Evans virgin female rats, at least 90 days of age and having regular estrous cycles, were used. All sub jects had received a single injection of morphine sulfate (3 mg/kg) some weeks prior to the start of Experiment 2. They were housed and fed identically to the rats in Experiment 1. Testing was conducted between 0800 and 1030 hr.
Apparatlls
The TFL-testing apparatus was the same as that used in Experiment 1.
Procedure
The procedures were the same as those used in Experi ment 1 for the morphine-treated rats, except that the dish containing either beef bouillon + beef (Group BB/Expose) or amniotic fluid + beef (Group AF/Expose) was placed 5 cm beneath the center of the subject's cage. These subjects were exposed to amniotic fluid and bouillon before the test, as were the subjects in Experiment 1.
The rats in this experiment were compared to those of Clearly, sensory exposure to amniotic fluid (and beef) did not enhance morphine-induced analgesia, whereas ingestion of amniotic fluid (and beef) did.
EXPERIMENT 3
It is possible that the enhancing effect of amniotic fluid ingestion on morphine analgesia, as observed in Experiment 1, was due to oropharyngeal factors such as the taste, tex ture, or effect on mouth tissues, rather than due to the effect of the fluid in, or absorbed by, the stomach or intestine. It is also possible that the effect seen in Experiment I was the result of an interaction between amniotic fluid and beef. To test for these possible confounds, we examined the effect on morphine analgesia of amniotic fluid delivered directly to the stomach by means of an orogastric tube.
METHOD
Subjects
Eight virgin adult Long-Evans female rats, with regular estrous cycles, were used as subjects. They were housed and maintained as described in Experiment 1.
Apparatus
The experimental and control fluids were administered by means of an orogastric tube consisting of a 3.65-cm curved, stainless steel intubation needle, having a 2.25-mm ball end (Popper, Inc.). The needle was fitted to a l-cc tuberculin syringe.
Pain thresholds were assessed using the TFL testing apparatus described in Experiment 1. Amniotic fluid was collected and stored as described in Experiment 1. Bouillon was mixed and stored as described in Experiment 1. These fluids were administered in a volume of 1 ml over a period of 1 min, to rats that had been food and water deprived for 3 hr. Each rat had been intubated five times before the first test day (no fluid was infused).
Testing was conducted between 0800 and 1400 hr.
RESULTS AND DISCUSSION
The baseline mean TFLs (Tb) did not differ among the groups. They ranged from 3.29±0.16 sec (Group S/AF) to 3.48±0.06 sec (Group M/BB), F(l,32)<1.00.
The results of the third experiment are presented in Fig.  3 . As in Experiment 1, the ingestion of amniotic fluid en hanced morphine analgesia, even when the amniotic fluid was delivered by stomach tube. The 3-way ANOYA re vealed a significant Fluid x Drug interaction, F(l,7)=7.97, p<0.05, and a significant effect of Time, F(4,28)=7.55, p<O.OI (with a Greenhouse-Geisser correction).
The saline-injected rats (Groups S/AF and SIB B) showed no significant change from baseline TFL. The morphine-injected group that received amniotic fluid had significantly longer TFLs than all other groups, and than its own baseline, at T IO , F(l,32)=8.21, p<O.OI, and Tao, F(l,32)=7.21, p<O.01. By T 7 (), however, Group M/AF had TFLs that were significantly longer than only Group M/BB, F(l,62)=6.79, p<O.01. By T 150, there were no statistically significant differences among the groups.
Although some of the rats that were injected with a threshold dose of morphine, and that also received bouillon (Group M/BB), showed an elevation ofTFL at T:w, the group did not differ significantly from the saline-injected groups.
These data were consistent with those of Experiment 1 and previous studies [15, 16] in also showing that amniotic fluid ingestion, in the absence of opiate-induced analgesia, does not produce analgesia.
EXPERIMENT 4
To verify that amniotic fluid specifically enhances the opiate-mediated effects of morphine, rats were tested in a design similar to that used in Experiment 3, except that half of them received treatment with the opiate-blocker naltrexone as part of the protocol.
METHOD
Subjects
Fifteen Long-Evans female rats, 90-150 days old, that had demonstrated regular estrous cyclicity were used. They were housed and maintained as described in Experiment 1.
Apparatus
The intubation instrument was an improved version of that described in Experiment 3; rather than a steel intubation needle, we used a blunted section of PE 20i tubing fitted to a 16-ga hypodermic needle.
Pain thresholds were assessed using the same TFL testing apparatus described in the preceding experiments.
Procedure
Each rat was assigned to one of the two Fluid groups (amniotic fluid, Group AF, n=8; beef bouillon, Group BB, n=7) and tested in each of two Drug conditions (naltrexone, saline). All rats received morphine (3 mg/kg, IP) on both tests, which occurred 1 week apart, and were balanced so that half the rats were tested with naltrexone first and the remainder tested with saline first. Each test consisted of sev eral TFL determinations, resulting in a 2x2x4 design: Fluid (amniotic fluid, beef bouillon) x Drug (naltrexone, saline) x Time, with repeated measures on the Drug and Time variables.
Since both morphine and Drug were injected, the se quence of procedures was slightly different from that de scribed in Experiment 3. The rats were habituated to the restrainer and to the intubation procedure prior to testing, as described previously. Food and water were removed 3 hr prior to the test. For the test, first a Pre-Naltrexone/Pre Morphine baseline was determined. This was followed im mediately by a Drug injection (naltrexone, 5 mg/kg Sc, or saline, 1 ml SC). After 20 min, a Post-Naltrexone/Pre Morphine baseline was determined (Til), and a morphine in jection administered. Fifteen minutes later, the amniotic fluid or beef bouillon was intubated, and after 10 min (T lO ) and 30 min (Tao), TFLs were again measured.
RESULTS AND DISCUSSION
A 2-way ANOYA determined that the Pre-Naltrexonel Pre-Morphine and Post-Naltrexone/Pre-Morphine baselines were the same for both the naltrexone and saline groups (naltrexone: Pre=3.36±0.08 sec; Post=3.33±0.07 sec; saline: Pre=3.36±0.06 sec; Post=3.25±0.04 sec; F(l,14)= 1.04, p>0.05). Since the Pre-Naltrexone/Pre-Morphine and Post-Naltrexone/Pre-Morphine baselines were the same, only the Post-Naltrexone/Pre-Morphine baseline was used for subsequent comparisons.
The results of Experiment 4 are summarized in Table 1 . As in Experiment 3, in the absence ofnaltrexone, amniotic fluid significantly heightened morphine-induced analgesia at both 10 and 30 min after ingestion, F(2,52)=49.00, p<O.01. In the presence of naltrexone, however, not only was there no effect of morphine on TFL, but amniotic fluid, too, was ineffective, F(2,52)< 1.00. This is consonant with our previ ous report that the enhancing effect of placenta is specific to opiate-mediated analgesia [15] .
GENERAL DISCUSSION
In Experiment 1 we showed that ingestion of amniotic Ifluid enhances opiate-mediated analgesia, but although the Ifluid contains opioids [11] , it is not, by itself, an analgesic.
IThese results are consistent with our prevIous reports on the effects of placenta-ingestion on opiate-mediated analgesia [15, 16] . In Experiment 2 we demonstrated that the effect of amniotic fluid on opiate-mediated analgesia is the result of ingestion of the fluid, not a reaction to the smell and sight of the substance. In Experiment 3 we demonstrated that deliv ery of the fluid directly to the stomach, by means of an orogastric tube, led to the enhancement effect, suggesting that oropharyngeal factors such as taste (although that was not entirely ruled out by the intubation procedure), texture, and the necessity for chemical changes produced by compo nents of saliva, were not important. In Experiment 4 we demonstrated that the analgesia-enhancing effect of amniotic-fluid ingestion is specific to the opiate-mediated analgesia produced by morphine. The dose of morphine used (3 mg/kg) was chosen because it is close to the threshold dose for the production of analgesia. In the present experiments, however, the eleva tion of TFL produced by morphine alone was considerably less than that in our previous reports. The rats in the earlier reports [15, 16] had had no previous exposure to morphine, whereas in the present experiments, the rats had had a prior morphine injection (Experiments 1 and 2) or had two injec tions during the course of the experiment (Experiments 3 and 4). We have found that the TFL responses to 3 mg/kg mor phine are smaller and less variable if the rats had received a previous injection of the same dose of morphine weeks ear lier. In the feeding paradigm, which was used in this and in our previous reports, the first morphine injection elevated TFL by about 35%, but if the procedure was repeated weeks later, the same dose of morphine only produced an incre';lse KRISTAL, THOMPSON AND ABBOTT in TFL of about 10%. In the intubation paradigm (such as that used in Experiments 3 and 4), the initial morphine treatment elevated TFL by about 20%, whereas a repetition weeks later produced an elevation of about 12%. This altera tion in the response to morphine by as few as one prior treatment has been reported previously [10] .
The finding that ingestion of amniotic fluid enhances opiate-mediated analgesia, as does ingestion of placenta, is particularly important for building a case that analgesia enhancement is a major advantage of ingesting amniotic fluid and placenta during and after delivery. If ingestion only of placenta produced enhancement of opiate analgesia, we would be hard-pressed to explain what advantage this would have for mothers delivering only one neonate. The need to reduce pain and discomfort is probably less after delivery (when the placenta becomes available) than it is during de livery. Amniotic fluid ingestion, though, also produces enhancement of opiate analgesia; since amniotic fluid is available early in the delivery process, and has an effect within minutes of ingestion, the advantage, as a reduction of pain during delivery, would be significant even to monotoc ous mothers. Of course, it is possible that, as we have hy pothesized, the significant advantage of placentophagia is opiate-enhancement, but that the important opiate effect en hanced is not analgesia, but another process. Enhanced analgesia, therefore, might just be a desirable side-effect.
